Charles M. Rudin
Memorial Sloan Kettering Cancer Center
Affiliation Memorial Sloan Kettering Cancer Center Top Publications Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer (2015) – 9,582 citations Tumor mutational load predicts survival after immunotherapy across multiple cancer types (2019) – 4,468 citations Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs (2014) – 1,766 citations STK11/LKB1 Mutations ... <a title="Charles M. Rudin" class="read-more" href="https://journalsworld.com/researchers/charles-m-rudin/" aria-label="Read more about Charles M. Rudin">Read more</a>
Read biography ↓Biography, research & contributions
Affiliation
Memorial Sloan Kettering Cancer Center
Top Publications
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer (2015) - 9,582 citations
- Tumor mutational load predicts survival after immunotherapy across multiple cancer types (2019) - 4,468 citations
- Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs (2014) - 1,766 citations
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma (2018) - 1,685 citations
- Small-cell lung cancer (2021) - 1,641 citations
At a glance
- Full name
- Charles M. Rudin
- ORCID
- 0000-0001-5204-3465
- OpenAlex ID
- https://openalex.org/A5049524331
Research interests
- Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers, Cancer Genomics and Diagnostics, Lung Cancer Diagnosis and Treatment
Research topics
Education
Not yet documented in this profile.
Selected research & further reading
A curated reading list, not a ranking by citation count. References use DOI metadata, matching public scholarly records or authoritative lecture sources.
See the source-linked reading and original works in the research guide above.
Citation & publication trends
Annual counts are not yet available from a verified author record. Explore the research guide above for the work itself; publication and citation totals depend on database coverage.
Source: OpenAlex · Retrieved 2026-10-07. Metrics are database-specific and are not a scientific ranking.
Most-cited linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer ↗2015 · New England Journal of Medicine9,582OpenAlex citations
- 4,468OpenAlex citations
- 1,766OpenAlex citations
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma ↗2018 · Cancer Discovery1,685OpenAlex citations
- Small-cell lung cancer ↗2021 · Nature Reviews Disease Primers1,641OpenAlex citations
Recent linked publications
Publications matched across ORCID and OpenAlex. Citation counts are source-specific.
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer ↗2015 · New England Journal of Medicine
- STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS -Mutant Lung Adenocarcinoma ↗2018 · Cancer Discovery
- Small-cell lung cancer ↗2021 · Nature Reviews Disease Primers
Journals published in
No verified record links added yet.
Related publishers
No verified record links added yet.
Institutions
Current verified institution
No verified record links added yet.
Previous institutions
No verified record links added yet.
Awards & honors
Not yet documented in this profile.
Career timeline
Not yet documented in this profile.
Co-authors
No verified record links added yet.
Education & career institution links
No verified record links added yet.
Claim & manage this profile
Are you this researcher? Sign in, provide identity evidence, and request administrator approval. Editing becomes available only after approval.
Sign in to claim this profileSources & data information
Editorial review: 2026-10-07 · Last data update: 2026-10-07 21:01:53
Unknown values are left blank. Linked publications may be a subset of total works. Identity verification, data retrieval and profile ownership are separate checks.